Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy

Figure 2

Choline compound over creatine signal ratios (A-C) and normalized choline compound integrals (D-F) of docetaxel resistant and sensitive tumor tissue samples pre- and post-treatment. Docetaxel resistant and sensitive tumor samples were monitored pretreatment at day 0 and after treatment at time points 1-2, 3-5 and 6-7 days. Statistical significant differences are indicated with an asterisk (*p < 0.05, **p < 0.01). The number of samples of resistant and sensitive tumor tissue for the different time points were: [7,5], [7,5], [5,5] and [4,4].

Back to article page